AmerisourceBergen’s Lash Group unveils Fusion to power patient support
FORT MILL, S.C. — AmerisourceBergen’s Lash Group this week unveiled Fusion, a new tech ecosystem for patient support. Fusion is designed to go beyond being a customer relationship management platform, bringing together technologies with workflows customized for patients support services, and offering a proprietary advanced data model that lets the Lash Group provide patients, providers and manufacturers a personalized experience, the company said.
“Pharmaceutical manufacturers face a growing array of new challenges in the market. Intense competition, rising commercialization costs, disaggregated data, consumerism and a shift to value-based care are key issues that complicate the commercialization process,” AmerisourceBergen group president global commercialization services and animal health Jim Cleary said. “Fusion enables Lash Group to provide greater support to manufacturers, while also increasing efficiency and providing a more comprehensive set of services throughout the patient journey and product lifecycle.”
Fusion was developed to streamline administrative tasks through to speed access to treatment, using artificial intelligence for benefit verification and leveraging multichannel communication capabilities to remove common barriers to therapy. Fusion also looks to create a simpler set of patient-provider interactions through such features as computer-telephony integration. And the platform can generate actionable insights for manufacturers through data management, real-time reports and dashboards, as well as targeted analytics, competitive intelligence and a more holistic view of the patient experience, the company said.
“There is no stronger example of AmerisourceBergen’s commitment to innovation and our ability to develop and deploy technologies that advance healthcare than Fusion,” AmerisourceBergen chief information officer Dale Danilewitz said. “By combining Lash Group’s high-tech, smart-touch service model with dozens of proven tools and the company's deep expertise across life sciences, we’re producing a seamless, end-to-end experience for manufacturers, providers and most importantly, patients.”
No comments found